Anti-Müllerian Hormone as a Diagnostic Marker for Equine Cryptorchidism in Three Cases with Equivocal Testosterone Concentrations

Cryptorchidism is a developmental disorder which can be diagnosed by a variety of different tests. Still, equine field veterinarians often rely on endocrine markers to detect retained testicular tissue. This report describes the value of anti-Müllerian hormone (AMH) as a diagnostic marker for cryptorchidism in three stallions suspected of cryptorchidism, with equivalent serum testosterone concentrations. A single measurement of AMH identified cryptorchidism, with inconclusive testosterone concentrations as either gelding or stallion. Furthermore, a human chorionic gonadotropin (hCG) stimulation test or surgery was performed to support the diagnostic value of AMH. To conclude, the endocrine panel for cryptorchidism should be expanded to include determination of serum AMH, as this determination can increase the diagnostic accuracy of a single blood sample.     

Investigation of the Role of Androstenedione-19-oic Acid in the Presence of 19-Norandrostenedione in Intact Male Horse Plasma Using Liquid Chromatography–Tandem Mass Spectrometry

A liquid chromatography–tandem mass spectrometry method was developed to confirm the presence of androstenedione-19-oic acid in intact male equine plasma and to show the source of 19-norandrostenedione in equine plasma. Androstenedione-19-oic acid was recovered from acidified plasma by liquid–liquid extraction using methyl tert-butyl ether and separated on an Ace 5 C₈ column. A triple quadrupole mass spectrometer was used to detect the analytes in negative electrospray ionization mode. Limits of detection, quantification, and confirmation of the method were 0.1, 0.5, and 1.0 ng/mL, respectively. The linear dynamic range of quantification was 0.5–50 ng/mL. The presence of androstenedione-19-oic acid was confirmed in all plasma samples obtained from intact male horses but not those from gelded and female horses; the average concentration was 3.1 ± 1.6 ng/mL, suggesting androstenedione-19-oic acid is an endogenous compound only in intact male horse plasma samples. The conversion of androstenedione-19-oic acid to 19-norandrostenedione in equine plasma was demonstrated by spiking androstenedione-19-oic acid into blank plasma and monitoring the generation of 19-norandrostenedione and its increase in concentration during storage. Results indicated that androstenedione-19-oic acid was readily converted into 19-norandrostenedione; the higher the storage temperature, the faster the conversion. The conversion was not affected by the types of plasma samples collected from gelded and female horses or by anticoagulants used in blood collection to harvest plasma. Compared with other matrices such as water, methanol, and phosphate-buffered saline, the conversion of androstenedione-19-oic to 19-norandrostenedione in equine plasma was faster, suggesting that there is an unknown factor(s) in equine plasma that enhances the conversion.     

世界乳业的资本和贸易流动

2006年10月20日,第27届IDF世界乳业大会在上海召开。作为十大专题会议之一的“全球乳业高层论坛”引起中外代表的极大关注。论坛上,国内外乳业高层针对全球乳品产业链的发展趋势和乳业新兴国家的协作与机遇作了精彩报告,为本土企业提供了向乳业跨国公司首席执行官沟通、学习的机会。本刊编辑部对各位乳业高层的发言进行了整理,现刊登如下,以飨读者。     

No easy solution for the fractionation of faecal nitrogen in captive wild herbivores: results of a pilot study

Faecal nitrogen (FN) concentration is used as a marker for habitat quality and digestive efficiency in free‐ranging herbivores. In herbivores, FN can be separated into undigested plant N (analysed as the N concentration of the neutral detergent residue) and metabolic faecal N (MFN). It has been suggested that by differential analysis of the faecal fibre‐bound N, the MFN fraction can be further split into a bacterial N and an endogenous N fraction [Hesta et al., Br. J. Nutr. 90 (2003) 1007]. We applied these methods to 96 faecal samples of 48 mammalian herbivore species from zoos. Species were grouped into coprophageous and non‐coprophageous hindgut fermenters and ruminating and non‐ruminating foregut fermenters. Diet was not controlled. The FN decreased with body mass, possibly reflecting higher proportions of concentrates in diets of smaller animals. The proportion of MFN increased with FN, indicating that higher quality food might enhance the gastrointestinal bacterial flora. The only outlier to this pattern was the lesser panda (Ailurus fulgens), confirming the low relevance of fermentative digestion in this herbivorous ‘carnivore’. No relevant differences between the four digestion types were noted. The proportion of endogenous faecal N (32–80% of FN) was always higher than that of bacterial faecal N (7–30%), which contradicts basal understanding of herbivore digestive physiology. Thus, the method of Hesta et al. (2003) does not appear applicable to herbivores. While the results do not exclude the possibility that detailed differences might occur between digestion types, they indicate a high degree of similarity between herbivores that rely on bacterial fermentation, regardless of their digestion type, with respect to metabolic faecal losses.     

Type 2 diabetes mellitus with pancreatic β cell dysfunction in 3 horses confirmed with minimal model analysis

Reasons for performing study: Type 2 diabetes mellitus (T2DM) is diagnosed rarely in equine practice although it may be under‐recognised. A greater awareness of the condition and therapeutic considerations would be to the benefit of such cases presenting in practice. More investigation into the pharmacological management of these cases is needed. Objectives: Three cases of diabetes mellitus were investigated using a specific test for insulin sensitivity and pancreatic β cell function in order to define accurately and characterise the existence of T2DM in all 3 subjects. Methods: The insulin‐modified frequently sampled i.v. glucose tolerance test was performed in each case and the data so obtained were subject to minimal model analysis of insulin‐glucose dynamics. Cases were then monitored following treatment using a combination of dietary modification, metformin, glibenclamide and pergolide. Results: Marked insulin resistance was identified in each case and, furthermore, severe pancreatic β cell dysfunction was present therefore classifying each case as end stage T2DM. Treatment was nevertheless associated with restoration of normoglycaemia in all cases. Conclusions: T2DM in horses may be more common than generally considered. In some cases individuals may respond to therapy aimed at restoring insulin sensitivity and pancreatic function. Drugs used in other species for the treatment of T2DM have not yet been adequately tested in horses. Potential relevance: T2DM should be considered as an important differential diagnosis in mature to elderly horses and ponies suffering from weight loss, polydipsia and polyuria. Clinicians should be encouraged to offer treatment and management advice when such cases are encountered.     

Surgical management of a pony with a traumatic medial luxation of the patella

This report describes a successful surgical repair of medial patellar luxation in a Miniature Shetland pony where manual reduction of the patella was not possible. The surgical procedure involves transection of the medial femoropatellar ligament to facilitate patellar release, the placement of a prosthetic suture to replace the lateral femoropatellar ligament and reinforcement of the lateral retinaculum by the use of a mesh implant. This is a newly described surgical technique for the rare but recognised condition of a medial luxation of the patella.